nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—sarcoma—acquired immunodeficiency syndrome	0.52	1	CtDrD
Thiotepa—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0479	0.133	CbGbCtD
Thiotepa—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.045	0.125	CbGbCtD
Thiotepa—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.045	0.125	CbGbCtD
Thiotepa—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0407	0.113	CbGbCtD
Thiotepa—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0341	0.0947	CbGbCtD
Thiotepa—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0308	0.0857	CbGbCtD
Thiotepa—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0147	0.0408	CbGbCtD
Thiotepa—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0138	0.0384	CbGbCtD
Thiotepa—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0138	0.0384	CbGbCtD
Thiotepa—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0125	0.0347	CbGbCtD
Thiotepa—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0125	0.0347	CbGbCtD
Thiotepa—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0108	0.03	CbGbCtD
Thiotepa—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0105	0.0291	CbGbCtD
Thiotepa—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00948	0.0263	CbGbCtD
Thiotepa—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00948	0.0263	CbGbCtD
Thiotepa—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00908	0.0252	CbGbCtD
Thiotepa—Confusional state—Delavirdine—acquired immunodeficiency syndrome	8.58e-05	0.000719	CcSEcCtD
Thiotepa—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	8.58e-05	0.000719	CcSEcCtD
Thiotepa—Anaemia—Saquinavir—acquired immunodeficiency syndrome	8.58e-05	0.000719	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	8.58e-05	0.000719	CcSEcCtD
Thiotepa—Back pain—Lamivudine—acquired immunodeficiency syndrome	8.57e-05	0.000718	CcSEcCtD
Thiotepa—Pruritus—Nevirapine—acquired immunodeficiency syndrome	8.54e-05	0.000715	CcSEcCtD
Thiotepa—Vomiting—Didanosine—acquired immunodeficiency syndrome	8.53e-05	0.000715	CcSEcCtD
Thiotepa—Agitation—Saquinavir—acquired immunodeficiency syndrome	8.53e-05	0.000715	CcSEcCtD
Thiotepa—Anorexia—Efavirenz—acquired immunodeficiency syndrome	8.48e-05	0.000711	CcSEcCtD
Thiotepa—Rash—Didanosine—acquired immunodeficiency syndrome	8.46e-05	0.000709	CcSEcCtD
Thiotepa—Infection—Delavirdine—acquired immunodeficiency syndrome	8.46e-05	0.000709	CcSEcCtD
Thiotepa—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	8.46e-05	0.000709	CcSEcCtD
Thiotepa—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	8.46e-05	0.000709	CcSEcCtD
Thiotepa—Dermatitis—Didanosine—acquired immunodeficiency syndrome	8.45e-05	0.000708	CcSEcCtD
Thiotepa—Cough—Ritonavir—acquired immunodeficiency syndrome	8.42e-05	0.000705	CcSEcCtD
Thiotepa—Headache—Didanosine—acquired immunodeficiency syndrome	8.41e-05	0.000704	CcSEcCtD
Thiotepa—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	8.39e-05	0.000703	CcSEcCtD
Thiotepa—Somnolence—Indinavir—acquired immunodeficiency syndrome	8.37e-05	0.000702	CcSEcCtD
Thiotepa—Asthenia—Stavudine—acquired immunodeficiency syndrome	8.36e-05	0.0007	CcSEcCtD
Thiotepa—Convulsion—Ritonavir—acquired immunodeficiency syndrome	8.36e-05	0.0007	CcSEcCtD
Thiotepa—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	8.35e-05	0.000699	CcSEcCtD
Thiotepa—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	8.34e-05	0.000699	CcSEcCtD
Thiotepa—Hypertension—Ritonavir—acquired immunodeficiency syndrome	8.33e-05	0.000698	CcSEcCtD
Thiotepa—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	8.31e-05	0.000696	CcSEcCtD
Thiotepa—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	8.31e-05	0.000696	CcSEcCtD
Thiotepa—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	8.29e-05	0.000695	CcSEcCtD
Thiotepa—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	8.28e-05	0.000694	CcSEcCtD
Thiotepa—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	8.27e-05	0.000693	CcSEcCtD
Thiotepa—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	8.27e-05	0.000693	CcSEcCtD
Thiotepa—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	8.26e-05	0.000692	CcSEcCtD
Thiotepa—Pruritus—Stavudine—acquired immunodeficiency syndrome	8.24e-05	0.000691	CcSEcCtD
Thiotepa—Asthenia—Abacavir—acquired immunodeficiency syndrome	8.24e-05	0.00069	CcSEcCtD
Thiotepa—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	8.21e-05	0.000688	CcSEcCtD
Thiotepa—Myalgia—Ritonavir—acquired immunodeficiency syndrome	8.21e-05	0.000688	CcSEcCtD
Thiotepa—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	8.19e-05	0.000686	CcSEcCtD
Thiotepa—Anaemia—Lamivudine—acquired immunodeficiency syndrome	8.19e-05	0.000686	CcSEcCtD
Thiotepa—Anxiety—Ritonavir—acquired immunodeficiency syndrome	8.18e-05	0.000686	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	8.16e-05	0.000683	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	8.13e-05	0.000681	CcSEcCtD
Thiotepa—Pruritus—Abacavir—acquired immunodeficiency syndrome	8.12e-05	0.00068	CcSEcCtD
Thiotepa—Fatigue—Indinavir—acquired immunodeficiency syndrome	8.12e-05	0.00068	CcSEcCtD
Thiotepa—Anorexia—Delavirdine—acquired immunodeficiency syndrome	8.12e-05	0.00068	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	8.11e-05	0.000679	CcSEcCtD
Thiotepa—Cough—Saquinavir—acquired immunodeficiency syndrome	8.1e-05	0.000679	CcSEcCtD
Thiotepa—Constipation—Indinavir—acquired immunodeficiency syndrome	8.05e-05	0.000675	CcSEcCtD
Thiotepa—Pain—Indinavir—acquired immunodeficiency syndrome	8.05e-05	0.000675	CcSEcCtD
Thiotepa—Urticaria—Zidovudine—acquired immunodeficiency syndrome	8.05e-05	0.000674	CcSEcCtD
Thiotepa—Convulsion—Saquinavir—acquired immunodeficiency syndrome	8.05e-05	0.000674	CcSEcCtD
Thiotepa—Hypertension—Saquinavir—acquired immunodeficiency syndrome	8.02e-05	0.000672	CcSEcCtD
Thiotepa—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	8.01e-05	0.000671	CcSEcCtD
Thiotepa—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	8.01e-05	0.000671	CcSEcCtD
Thiotepa—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	8e-05	0.00067	CcSEcCtD
Thiotepa—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	7.99e-05	0.00067	CcSEcCtD
Thiotepa—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	7.97e-05	0.000668	CcSEcCtD
Thiotepa—Nausea—Didanosine—acquired immunodeficiency syndrome	7.97e-05	0.000668	CcSEcCtD
Thiotepa—Confusional state—Ritonavir—acquired immunodeficiency syndrome	7.94e-05	0.000665	CcSEcCtD
Thiotepa—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	7.93e-05	0.000664	CcSEcCtD
Thiotepa—Somnolence—Efavirenz—acquired immunodeficiency syndrome	7.91e-05	0.000663	CcSEcCtD
Thiotepa—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	7.91e-05	0.000662	CcSEcCtD
Thiotepa—Myalgia—Saquinavir—acquired immunodeficiency syndrome	7.91e-05	0.000662	CcSEcCtD
Thiotepa—Anxiety—Saquinavir—acquired immunodeficiency syndrome	7.88e-05	0.00066	CcSEcCtD
Thiotepa—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	7.85e-05	0.000658	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	7.85e-05	0.000658	CcSEcCtD
Thiotepa—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	7.83e-05	0.000656	CcSEcCtD
Thiotepa—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	7.76e-05	0.00065	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	7.76e-05	0.00065	CcSEcCtD
Thiotepa—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	7.74e-05	0.000648	CcSEcCtD
Thiotepa—Cough—Lamivudine—acquired immunodeficiency syndrome	7.73e-05	0.000648	CcSEcCtD
Thiotepa—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	7.73e-05	0.000648	CcSEcCtD
Thiotepa—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	7.72e-05	0.000647	CcSEcCtD
Thiotepa—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	7.71e-05	0.000646	CcSEcCtD
Thiotepa—Dizziness—Stavudine—acquired immunodeficiency syndrome	7.7e-05	0.000646	CcSEcCtD
Thiotepa—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	7.7e-05	0.000645	CcSEcCtD
Thiotepa—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	7.68e-05	0.000644	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	7.68e-05	0.000644	CcSEcCtD
Thiotepa—Convulsion—Lamivudine—acquired immunodeficiency syndrome	7.67e-05	0.000643	CcSEcCtD
Thiotepa—Vomiting—Nevirapine—acquired immunodeficiency syndrome	7.67e-05	0.000643	CcSEcCtD
Thiotepa—Fatigue—Efavirenz—acquired immunodeficiency syndrome	7.67e-05	0.000643	CcSEcCtD
Thiotepa—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	7.65e-05	0.000641	CcSEcCtD
Thiotepa—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	7.65e-05	0.000641	CcSEcCtD
Thiotepa—Confusional state—Saquinavir—acquired immunodeficiency syndrome	7.64e-05	0.00064	CcSEcCtD
Thiotepa—Constipation—Efavirenz—acquired immunodeficiency syndrome	7.61e-05	0.000638	CcSEcCtD
Thiotepa—Pain—Efavirenz—acquired immunodeficiency syndrome	7.61e-05	0.000638	CcSEcCtD
Thiotepa—Rash—Nevirapine—acquired immunodeficiency syndrome	7.61e-05	0.000638	CcSEcCtD
Thiotepa—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	7.6e-05	0.000637	CcSEcCtD
Thiotepa—Dizziness—Abacavir—acquired immunodeficiency syndrome	7.59e-05	0.000636	CcSEcCtD
Thiotepa—Somnolence—Delavirdine—acquired immunodeficiency syndrome	7.57e-05	0.000634	CcSEcCtD
Thiotepa—Headache—Nevirapine—acquired immunodeficiency syndrome	7.56e-05	0.000633	CcSEcCtD
Thiotepa—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	7.54e-05	0.000632	CcSEcCtD
Thiotepa—Myalgia—Lamivudine—acquired immunodeficiency syndrome	7.54e-05	0.000632	CcSEcCtD
Thiotepa—Infection—Saquinavir—acquired immunodeficiency syndrome	7.53e-05	0.000631	CcSEcCtD
Thiotepa—Anxiety—Lamivudine—acquired immunodeficiency syndrome	7.52e-05	0.00063	CcSEcCtD
Thiotepa—Anorexia—Ritonavir—acquired immunodeficiency syndrome	7.51e-05	0.000629	CcSEcCtD
Thiotepa—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	7.49e-05	0.000628	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	7.49e-05	0.000628	CcSEcCtD
Thiotepa—Urticaria—Indinavir—acquired immunodeficiency syndrome	7.48e-05	0.000627	CcSEcCtD
Thiotepa—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	7.45e-05	0.000624	CcSEcCtD
Thiotepa—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	7.45e-05	0.000624	CcSEcCtD
Thiotepa—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	7.43e-05	0.000623	CcSEcCtD
Thiotepa—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	7.43e-05	0.000623	CcSEcCtD
Thiotepa—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	7.42e-05	0.000622	CcSEcCtD
Thiotepa—Vomiting—Stavudine—acquired immunodeficiency syndrome	7.41e-05	0.000621	CcSEcCtD
Thiotepa—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	7.4e-05	0.00062	CcSEcCtD
Thiotepa—Rash—Nelfinavir—acquired immunodeficiency syndrome	7.37e-05	0.000617	CcSEcCtD
Thiotepa—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	7.36e-05	0.000617	CcSEcCtD
Thiotepa—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	7.36e-05	0.000617	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	7.35e-05	0.000616	CcSEcCtD
Thiotepa—Rash—Stavudine—acquired immunodeficiency syndrome	7.35e-05	0.000616	CcSEcCtD
Thiotepa—Fatigue—Delavirdine—acquired immunodeficiency syndrome	7.34e-05	0.000615	CcSEcCtD
Thiotepa—Dermatitis—Stavudine—acquired immunodeficiency syndrome	7.34e-05	0.000615	CcSEcCtD
Thiotepa—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	7.33e-05	0.000614	CcSEcCtD
Thiotepa—Headache—Nelfinavir—acquired immunodeficiency syndrome	7.32e-05	0.000613	CcSEcCtD
Thiotepa—Headache—Stavudine—acquired immunodeficiency syndrome	7.3e-05	0.000612	CcSEcCtD
Thiotepa—Vomiting—Abacavir—acquired immunodeficiency syndrome	7.3e-05	0.000612	CcSEcCtD
Thiotepa—Confusional state—Lamivudine—acquired immunodeficiency syndrome	7.29e-05	0.000611	CcSEcCtD
Thiotepa—Pain—Delavirdine—acquired immunodeficiency syndrome	7.28e-05	0.00061	CcSEcCtD
Thiotepa—Constipation—Delavirdine—acquired immunodeficiency syndrome	7.28e-05	0.00061	CcSEcCtD
Thiotepa—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	7.28e-05	0.00061	CcSEcCtD
Thiotepa—Asthenia—Zidovudine—acquired immunodeficiency syndrome	7.27e-05	0.000609	CcSEcCtD
Thiotepa—Rash—Abacavir—acquired immunodeficiency syndrome	7.24e-05	0.000606	CcSEcCtD
Thiotepa—Dermatitis—Abacavir—acquired immunodeficiency syndrome	7.23e-05	0.000606	CcSEcCtD
Thiotepa—Anorexia—Saquinavir—acquired immunodeficiency syndrome	7.22e-05	0.000605	CcSEcCtD
Thiotepa—Headache—Abacavir—acquired immunodeficiency syndrome	7.19e-05	0.000603	CcSEcCtD
Thiotepa—Infection—Lamivudine—acquired immunodeficiency syndrome	7.18e-05	0.000602	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	7.17e-05	0.000601	CcSEcCtD
Thiotepa—Nausea—Nevirapine—acquired immunodeficiency syndrome	7.17e-05	0.000601	CcSEcCtD
Thiotepa—Pruritus—Zidovudine—acquired immunodeficiency syndrome	7.16e-05	0.0006	CcSEcCtD
Thiotepa—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	7.09e-05	0.000594	CcSEcCtD
Thiotepa—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	7.08e-05	0.000593	CcSEcCtD
Thiotepa—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	7.07e-05	0.000592	CcSEcCtD
Thiotepa—Urticaria—Efavirenz—acquired immunodeficiency syndrome	7.07e-05	0.000592	CcSEcCtD
Thiotepa—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	7.03e-05	0.000589	CcSEcCtD
Thiotepa—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	7.03e-05	0.000589	CcSEcCtD
Thiotepa—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	7.02e-05	0.000588	CcSEcCtD
Thiotepa—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	7.02e-05	0.000588	CcSEcCtD
Thiotepa—Somnolence—Ritonavir—acquired immunodeficiency syndrome	7e-05	0.000586	CcSEcCtD
Thiotepa—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	6.96e-05	0.000583	CcSEcCtD
Thiotepa—Nausea—Nelfinavir—acquired immunodeficiency syndrome	6.94e-05	0.000582	CcSEcCtD
Thiotepa—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	6.94e-05	0.000581	CcSEcCtD
Thiotepa—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	6.93e-05	0.000581	CcSEcCtD
Thiotepa—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	6.93e-05	0.000581	CcSEcCtD
Thiotepa—Nausea—Stavudine—acquired immunodeficiency syndrome	6.92e-05	0.00058	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	6.9e-05	0.000579	CcSEcCtD
Thiotepa—Anorexia—Lamivudine—acquired immunodeficiency syndrome	6.89e-05	0.000577	CcSEcCtD
Thiotepa—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	6.84e-05	0.000573	CcSEcCtD
Thiotepa—Nausea—Abacavir—acquired immunodeficiency syndrome	6.82e-05	0.000571	CcSEcCtD
Thiotepa—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	6.8e-05	0.00057	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	6.8e-05	0.00057	CcSEcCtD
Thiotepa—Fatigue—Ritonavir—acquired immunodeficiency syndrome	6.79e-05	0.000569	CcSEcCtD
Thiotepa—Urticaria—Delavirdine—acquired immunodeficiency syndrome	6.76e-05	0.000567	CcSEcCtD
Thiotepa—Asthenia—Indinavir—acquired immunodeficiency syndrome	6.76e-05	0.000566	CcSEcCtD
Thiotepa—Somnolence—Saquinavir—acquired immunodeficiency syndrome	6.74e-05	0.000564	CcSEcCtD
Thiotepa—Pain—Ritonavir—acquired immunodeficiency syndrome	6.73e-05	0.000564	CcSEcCtD
Thiotepa—Constipation—Ritonavir—acquired immunodeficiency syndrome	6.73e-05	0.000564	CcSEcCtD
Thiotepa—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	6.73e-05	0.000564	CcSEcCtD
Thiotepa—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	6.73e-05	0.000564	CcSEcCtD
Thiotepa—Dizziness—Zidovudine—acquired immunodeficiency syndrome	6.7e-05	0.000561	CcSEcCtD
Thiotepa—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	6.67e-05	0.000559	CcSEcCtD
Thiotepa—Pruritus—Indinavir—acquired immunodeficiency syndrome	6.66e-05	0.000558	CcSEcCtD
Thiotepa—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	6.59e-05	0.000552	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	6.59e-05	0.000552	CcSEcCtD
Thiotepa—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	6.56e-05	0.000549	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	6.54e-05	0.000548	CcSEcCtD
Thiotepa—Fatigue—Saquinavir—acquired immunodeficiency syndrome	6.53e-05	0.000547	CcSEcCtD
Thiotepa—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	6.49e-05	0.000544	CcSEcCtD
Thiotepa—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	6.49e-05	0.000544	CcSEcCtD
Thiotepa—Pain—Saquinavir—acquired immunodeficiency syndrome	6.48e-05	0.000543	CcSEcCtD
Thiotepa—Constipation—Saquinavir—acquired immunodeficiency syndrome	6.48e-05	0.000543	CcSEcCtD
Thiotepa—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	6.44e-05	0.00054	CcSEcCtD
Thiotepa—Vomiting—Zidovudine—acquired immunodeficiency syndrome	6.44e-05	0.00054	CcSEcCtD
Thiotepa—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	6.44e-05	0.000539	CcSEcCtD
Thiotepa—Somnolence—Lamivudine—acquired immunodeficiency syndrome	6.43e-05	0.000539	CcSEcCtD
Thiotepa—Rash—Zidovudine—acquired immunodeficiency syndrome	6.39e-05	0.000535	CcSEcCtD
Thiotepa—Asthenia—Efavirenz—acquired immunodeficiency syndrome	6.38e-05	0.000535	CcSEcCtD
Thiotepa—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	6.38e-05	0.000535	CcSEcCtD
Thiotepa—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	6.36e-05	0.000533	CcSEcCtD
Thiotepa—Headache—Zidovudine—acquired immunodeficiency syndrome	6.34e-05	0.000532	CcSEcCtD
Thiotepa—Pruritus—Efavirenz—acquired immunodeficiency syndrome	6.3e-05	0.000528	CcSEcCtD
Thiotepa—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	6.28e-05	0.000527	CcSEcCtD
Thiotepa—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	6.27e-05	0.000526	CcSEcCtD
Thiotepa—Urticaria—Ritonavir—acquired immunodeficiency syndrome	6.25e-05	0.000524	CcSEcCtD
Thiotepa—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	6.24e-05	0.000523	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	6.24e-05	0.000523	CcSEcCtD
Thiotepa—Fatigue—Lamivudine—acquired immunodeficiency syndrome	6.23e-05	0.000522	CcSEcCtD
Thiotepa—Dizziness—Indinavir—acquired immunodeficiency syndrome	6.23e-05	0.000522	CcSEcCtD
Thiotepa—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	6.22e-05	0.000522	CcSEcCtD
Thiotepa—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	6.22e-05	0.000522	CcSEcCtD
Thiotepa—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	6.2e-05	0.000519	CcSEcCtD
Thiotepa—Pain—Lamivudine—acquired immunodeficiency syndrome	6.18e-05	0.000518	CcSEcCtD
Thiotepa—Constipation—Lamivudine—acquired immunodeficiency syndrome	6.18e-05	0.000518	CcSEcCtD
Thiotepa—Asthenia—Delavirdine—acquired immunodeficiency syndrome	6.11e-05	0.000512	CcSEcCtD
Thiotepa—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	6.09e-05	0.00051	CcSEcCtD
Thiotepa—Pruritus—Delavirdine—acquired immunodeficiency syndrome	6.02e-05	0.000505	CcSEcCtD
Thiotepa—Urticaria—Saquinavir—acquired immunodeficiency syndrome	6.02e-05	0.000504	CcSEcCtD
Thiotepa—Nausea—Zidovudine—acquired immunodeficiency syndrome	6.02e-05	0.000504	CcSEcCtD
Thiotepa—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	5.99e-05	0.000502	CcSEcCtD
Thiotepa—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.99e-05	0.000502	CcSEcCtD
Thiotepa—Vomiting—Indinavir—acquired immunodeficiency syndrome	5.99e-05	0.000502	CcSEcCtD
Thiotepa—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	5.96e-05	0.000499	CcSEcCtD
Thiotepa—Rash—Indinavir—acquired immunodeficiency syndrome	5.94e-05	0.000498	CcSEcCtD
Thiotepa—Dermatitis—Indinavir—acquired immunodeficiency syndrome	5.93e-05	0.000497	CcSEcCtD
Thiotepa—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	5.91e-05	0.000495	CcSEcCtD
Thiotepa—Headache—Indinavir—acquired immunodeficiency syndrome	5.9e-05	0.000494	CcSEcCtD
Thiotepa—Dizziness—Efavirenz—acquired immunodeficiency syndrome	5.88e-05	0.000493	CcSEcCtD
Thiotepa—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	5.83e-05	0.000488	CcSEcCtD
Thiotepa—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	5.8e-05	0.000486	CcSEcCtD
Thiotepa—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.74e-05	0.000481	CcSEcCtD
Thiotepa—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	5.71e-05	0.000479	CcSEcCtD
Thiotepa—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.71e-05	0.000479	CcSEcCtD
Thiotepa—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.66e-05	0.000474	CcSEcCtD
Thiotepa—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.65e-05	0.000473	CcSEcCtD
Thiotepa—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.63e-05	0.000472	CcSEcCtD
Thiotepa—Rash—Efavirenz—acquired immunodeficiency syndrome	5.61e-05	0.00047	CcSEcCtD
Thiotepa—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.61e-05	0.00047	CcSEcCtD
Thiotepa—Nausea—Indinavir—acquired immunodeficiency syndrome	5.59e-05	0.000469	CcSEcCtD
Thiotepa—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	5.58e-05	0.000468	CcSEcCtD
Thiotepa—Headache—Efavirenz—acquired immunodeficiency syndrome	5.57e-05	0.000467	CcSEcCtD
Thiotepa—Pruritus—Ritonavir—acquired immunodeficiency syndrome	5.57e-05	0.000467	CcSEcCtD
Thiotepa—Asthenia—Saquinavir—acquired immunodeficiency syndrome	5.44e-05	0.000456	CcSEcCtD
Thiotepa—Vomiting—Delavirdine—acquired immunodeficiency syndrome	5.41e-05	0.000454	CcSEcCtD
Thiotepa—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	5.39e-05	0.000451	CcSEcCtD
Thiotepa—Rash—Delavirdine—acquired immunodeficiency syndrome	5.37e-05	0.00045	CcSEcCtD
Thiotepa—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	5.36e-05	0.000449	CcSEcCtD
Thiotepa—Pruritus—Saquinavir—acquired immunodeficiency syndrome	5.36e-05	0.000449	CcSEcCtD
Thiotepa—Headache—Delavirdine—acquired immunodeficiency syndrome	5.33e-05	0.000447	CcSEcCtD
Thiotepa—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	5.33e-05	0.000446	CcSEcCtD
Thiotepa—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.29e-05	0.000443	CcSEcCtD
Thiotepa—Dizziness—Ritonavir—acquired immunodeficiency syndrome	5.21e-05	0.000436	CcSEcCtD
Thiotepa—Asthenia—Lamivudine—acquired immunodeficiency syndrome	5.19e-05	0.000435	CcSEcCtD
Thiotepa—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	5.18e-05	0.000434	CcSEcCtD
Thiotepa—Pruritus—Lamivudine—acquired immunodeficiency syndrome	5.11e-05	0.000429	CcSEcCtD
Thiotepa—Nausea—Delavirdine—acquired immunodeficiency syndrome	5.06e-05	0.000424	CcSEcCtD
Thiotepa—Dizziness—Saquinavir—acquired immunodeficiency syndrome	5.01e-05	0.00042	CcSEcCtD
Thiotepa—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.01e-05	0.000419	CcSEcCtD
Thiotepa—Rash—Ritonavir—acquired immunodeficiency syndrome	4.96e-05	0.000416	CcSEcCtD
Thiotepa—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.96e-05	0.000416	CcSEcCtD
Thiotepa—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.95e-05	0.000414	CcSEcCtD
Thiotepa—Headache—Ritonavir—acquired immunodeficiency syndrome	4.93e-05	0.000413	CcSEcCtD
Thiotepa—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.82e-05	0.000404	CcSEcCtD
Thiotepa—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.78e-05	0.000401	CcSEcCtD
Thiotepa—Rash—Saquinavir—acquired immunodeficiency syndrome	4.78e-05	0.0004	CcSEcCtD
Thiotepa—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.77e-05	0.0004	CcSEcCtD
Thiotepa—Headache—Saquinavir—acquired immunodeficiency syndrome	4.75e-05	0.000398	CcSEcCtD
Thiotepa—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.68e-05	0.000392	CcSEcCtD
Thiotepa—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.6e-05	0.000385	CcSEcCtD
Thiotepa—Rash—Lamivudine—acquired immunodeficiency syndrome	4.56e-05	0.000382	CcSEcCtD
Thiotepa—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.55e-05	0.000382	CcSEcCtD
Thiotepa—Headache—Lamivudine—acquired immunodeficiency syndrome	4.53e-05	0.000379	CcSEcCtD
Thiotepa—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.5e-05	0.000377	CcSEcCtD
Thiotepa—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.29e-05	0.00036	CcSEcCtD
